Results 131 to 140 of about 11,874 (152)

Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients

Journal of Neurology, 2014
Per Soelberg Sørensen, Nils Koch-Henriksen, Thor Petersen   +2 more
exaly  

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab

Multiple Sclerosis Journal, 2012
Per Soelberg Sørensen, Antonio Bertolotto, Gavin Giovannoni   +2 more
exaly  

Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study

Multiple Sclerosis Journal, 2015
Lilyana Amezcua, , Kerstin Hellwig
exaly  

Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment

Multiple Sclerosis Journal, 2011
Kerstin Hellwig, Ralf Gold
exaly  

Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis

Journal of the Neurological Sciences, 2014
Gabriel Pardo, Fiona Forrestal, P Duda   +2 more
exaly  

Natalizumab

Reactions Weekly, 2019
openaire   +2 more sources

Natalizumab

Reactions Weekly, 2014
  +4 more sources

Natalizumab in Multiple Sclerosis: Long-Term Management

International Journal of Molecular Sciences, 2017
Marinella Clerico, Carlo Alberto Artusi, Simona Rolla   +2 more
exaly  

Multiple sclerosis associated fatigue during natalizumab treatment

Journal of the Neurological Sciences, 2009
Norman Putzki, Özgur Yaldizli, Barbara Tettenborn   +2 more
exaly  

A review of the evidence for a natalizumab exit strategy for patients with multiple sclerosis

Autoimmunity Reviews, 2019
Johann Sellner, Paulus Rommer
exaly